Puma Biotechnology, Inc. drugs

1 result
  • nerlynx - neratinib tablet

    (Neratinib)
    Puma Biotechnology, Inc.
    Nerlynx is a kinase inhibitor for adults with HER2-positive breast cancer. Used alone for extended adjuvant treatment of early-stage disease following trastuzumab therapy, or with capecitabine for advanced or metastatic disease after two or more prior anti-HER2 regimens.